Melanoma Clinical Trials

Showing 1401-1420 of 1,477 trials

CP-675,206 In Patients With Advanced Melanoma

NCT00086489

The purpose of this study is to assess the efficacy, safety, and tolerability of monoclonal antibody therapy using 2 regimens for the treatment of advanced melanoma

Malignant Melanoma

AstraZeneca118 participantsStarted Aug 2003

Los Angeles, California, United States • Tampa, Florida, United States • Chicago, Illinois, United States +6 more locations

TERMINATEDPhase 2

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

NCT01026051

The clinical trial is evaluating a multi-component active immunotherapy designed to stimulate an immune reaction to specific tumor associated antigens which are highly expressed on melanoma

Stage III MelanomaStage IV Melanoma

Mannkind Corporation5 participantsStarted Oct 2010

Los Angeles, California, United States • Los Angeles, California, United States • Stuart, Florida, United States +1 more locations

COMPLETEDPhase 1/2

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

NCT00412425

Primary Objectives: * Safety of palonosetron administered for control of nausea and vomiting in patients with metastatic melanoma receiving biochemotherapy. * To determine the patterns and severity of nausea and vomiting in two groups of patients with metastatic melanoma receiving biochemotherapy with palonosetron premedication using two schedules of palonosetron administration.

Melanoma

M.D. Anderson Cancer Center30 participantsStarted Nov 2006

Houston, Texas, United States

CP-675,206 In Patients With Advanced Melanoma

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Related Searches

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

A Study of Volociximab in Metastatic Melanoma

Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma

Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System

Treatment of Port Wine Stains in Children With Pulsed Dye Laser and Timolol Gel

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma

Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma

A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine

Interstitial Fluid Pressure (IFP) Pilot Study in Melanoma Patients

Evaluation of Pigmented Skin Lesions With MelaFind(R) System

Survey Study - Sensitivity Comparison Between MelaFind and Physician Group

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma

Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Pharmacokinetics of G3139 in Subjects With Advanced Melanoma, Including Those With Normal Hepatic Function and Those With Moderate Hepatic Impairment